CHELLARAM
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks. We publish no number rather than a plausible-looking one.
Why · 2 checks
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
Our own committee reads this differently
Our rules-based factor scorecard scores this company's Value factor the opposite way to our fair value. Both cannot be right, so neither is presented as settled.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
- Agreement between the filing-derived valuation and the vendor ratios the committee scores.
Show what the engine computed
Method spread · 2.69× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 2.69x (Blended P/E band ₦4.49 vs Blended P/B band ₦12.09). No point estimate is defensible until the inputs are reconciled.
Committee disagrees · Committee scores Value POSITIVE (mixed) but our base fair value implies -30.2% downside.
Independent cross-check · independent data source eps ₦1.85 is 6.61x our ₦0.28, which is read from FY2026 of the filed accounts and agrees with the previous year's printed comparative. our independent data snapshot carries no period and is not corroborated here; our figure stands.
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.